Mendelian Randomization–Based Analysis of Causal Effects Between Statins and Common Upper Gastrointestinal Diseases
Gastroenterology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/grp/5335710 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Research and Practice, online erschienen am 29.10.2026. Verfasst von Wenchu Zhao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi University of Chinese Medicine Xianyang China sntcm.edu.cn. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Statins are widely used for cardiovascular disease prevention and exhibit multiple pleiotropic effects, including anti‐inflammatory properties. However, conclusions from observational studies regarding the causal relationship between statin use and upper gastrointestinal diseases (such as gastric cancer, gastric ulcer, and functional dyspepsia) remain controversial. This study is aimed at systematically evaluating the causal association between statin‐targeted gene (HMGCR)–mediated reductions in low‐density lipoprotein cholesterol (LDL‐C) levels and common upper gastrointestinal diseases using drug‐targeted Mendelian randomization (MR). This approach seeks to uncover potential unintended effects.
Methods
We extracted genetic variants associated with the HMGCR gene region from genome‐wide association studies (GWAS) as instrumental variables to simulate the lipid‐lowering effects of statins. Outcome data were derived from large‐scale GWAS meta‐analyses covering gastric cancer ( n = 202,308), gastroenteritis ( n = 7651), gastric ulcer ( n = 361,194), gastroesophageal reflux disease ( n = 462,933), and functional dyspepsia ( n = 84,572). The primary analysis employed inverse variance weighting (IVW), with sensitivity assessments for heterogeneity and pleiotropy conducted via MR‐Egger, weighted median, and MR‐PRESSO methods.
Results
Genetically predicted HMGCR‐mediated LDL‐C reduction was associated with reduced risk of gastric cancer (OR = 0.588, 95% CI: 0.423–0.816, p = 0.002), gastroenteritis (OR = 0.257, 95% CI: 0.086–0.766, p = 0.015), and gastric ulcer (OR = 0.996, 95% CI: 0.993–0.998, p = 0.003). However, analysis indicated a potential increased risk of functional dyspepsia (OR = 1.437, 95% CI: 1.014–2.036, p = 0.042). No significant causal association was found between statin use and gastroesophageal reflux disease (OR = 0.999, 95% CI: 0.992–1.006, p = 0.773). Sensitivity analyses confirmed the robustness of the results, with no evidence of significant level‐specific multiplicity.
Conclusion
This study provides genetic evidence supporting the potential protective effects of statins against gastric cancer, gastritis, and gastric ulcers, which may be associated with their anti‐inflammatory properties. However, the potential increased risk of functional dyspepsia suggests the complexity of the drug′s effects. These findings provide scientific basis for the repositioning of statins in gastrointestinal diseases and their safety assessment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shaanxi University of Chinese Medicine Xianyang China sntcm.edu.cn.
- Shaanxi University of Traditional Chinese Medicine Hospital Xianyang China.
ORCID-Profile: Wenchu Zhao, Jiejun Hou, Jinhua Pang
Zitieren
APA
Zhao, W., Hou, J., Chen, J., & Pang, J. (2026). Mendelian Randomization–Based Analysis of Causal Effects Between Statins and Common Upper Gastrointestinal Diseases. Gastroenterology Research and Practice, 2026(1). https://doi.org/10.1155/grp/5335710
Vancouver
Zhao W, Hou J, Chen J, Pang J. Mendelian Randomization–Based Analysis of Causal Effects Between Statins and Common Upper Gastrointestinal Diseases. Gastroenterology Research and Practice. 2026;2026(1). doi:10.1155/grp/5335710
BibTeX
@article{Zhao2026,
author = {Zhao, Wenchu and Hou, Jiejun and Chen, Jinyi and Pang, Jinhua},
title = {Mendelian Randomization–Based Analysis of Causal Effects Between Statins and Common Upper Gastrointestinal Diseases},
journal = {Gastroenterology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/grp/5335710}
}
EUVIMED